Where are we now in the fight to combat increasing antimicrobial resistance?
Following publication of Lord Jim O’Neill’s review on antimicrobial resistance, new guidance has been issued by NICE on antibiotic prescribing, and some progress has been achieved; however, there are many resistant infections that continue to pose a significant threat to public health.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide...